ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
Abstract Increasing evidence supports that ELL (eleven–nineteen lysine-rich leukaemia) is a key regulator of transcriptional elongation, but the physiological function of Ell in mammals remains elusive. Here we show that ELL functions as an E3 ubiquitin ligase and targets c-Myc for proteasomal degra...
Main Authors: | Yu Chen, Chi Zhou, Wei Ji, Zhichao Mei, Bo Hu, Wei Zhang, Dawei Zhang, Jing Wang, Xing Liu, Gang Ouyang, Jiangang Zhou, Wuhan Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2016-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms11057 |
Similar Items
-
Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
by: Yu Chen, et al.
Published: (2023-05-01) -
Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
by: Huy Minh Tran, et al.
Published: (2020-03-01) -
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation
by: Ke Li, et al.
Published: (2020-12-01) -
A nonautophagic role of ATG5 in regulating cell growth by targeting c-Myc for proteasome-mediated degradation
by: Sheng Li, et al.
Published: (2021-11-01) -
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
by: Yungang Wang, et al.
Published: (2020-08-01)